Biotech Company ATAI Life Sciences Plans to Purchase $5 Million in BTC

Odaily News Biopharmaceutical company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy and plans to initially invest $5 million in Bitcoin. Affected by the news, ATAI's stock price rose briefly. The company's chairman, Christian Angermayer, said that the company initially plans to invest $5 million in Bitcoin, while retaining enough cash, short-term securities and public equity to protect the company's operating funds until 2027.